CNXUConexeu Sciences Inc. Common Stock

8.890USD-0.78%Mkt Cap: 237.88M $P/E:

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a co…

Key Statistics

Company
Market Cap237.88M $
Enterprise Value245.49M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-3.92M $
Revenue/Share
Last Price8.890 USD
Fiscal Year EndOct 2025
MR QuarterApr 2026
Employees
CountryUS
SectorBasic Materials
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-17.79
PEG
EV/EBITDA-34.10
EV/Revenue
P/S
P/B27.41
EPS (TTM)-0.36
EPS (Forward)-0.53
52W Range
6.86017% of range18.79
52W High18.79 USD
52W Low6.860 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-53.36%
ROA-51.03%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-1.67M $
CapEx (TTM)18.67K $
FCF Margin
FCF Yield
Net Debt-6.84M $
Net Debt/EBITDA0.95
Balance Sheet
Debt/Equity0.05
Current Ratio7.89
Quick Ratio6.83
Book Value/Sh0.3440 USD
Cash/Share0.2560 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)20.00 USD
Upside (mean)+125.0%
Target Range20.00 USD20.00 USD
# Analysts1
Ownership
Shares Out.26.76M
Float15.56M
Insiders43.95%
Institutions0.10%
Short Interest
Short Ratio1.1d
Short % Out.0.55%
Shares Short170.67K
Short (prev mo.)37.34K
Technical
SMA 509.789 (-9.2%)
SMA 20010.73 (-17.1%)
Beta
S&P 52W Chg18.16%
Avg Vol (30d)171.36K
Avg Vol (10d)249.49K
Technical Indicators
RSI (14)49.2
MACD-0.1550
MACD Signal-0.3939
MACD Hist.+0.2388
BB Upper10.06 USD
BB Middle8.441 USD
BB Lower6.817 USD
BB Width38.46%
ATR (14)1.310 USD
Vol Ratio (20d)1.98x